EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Martin Breuer
Albert Schütz
Walter Eichinger
Josef Weingartner
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Breuer, M.
Right arrow Articles by Kemkes, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breuer, M.
Right arrow Articles by Kemkes, B.

Eur J Cardiothorac Surg 1999;15:266-270
© 1999 Elsevier Science NL


Intraoperative local fibrinolysis as emergency therapy after early coronary artery bypass thrombosis1

Martin Breuer, Albert Schütz, Brigitte Gansera, Walter Eichinger, Josef Weingartner, Bernhard Kemkes

Department of Cardiovascular Surgery, Klinikum Bogenhausen, Munich, Germany

Received 22 September 1998; received in revised form 14 December 1998; accepted 22 December 1998.

Corresponding author. Tel.: +49-89-9270-2697; fax: +49-89-9270-2605.

Objective: Acute graft occlusion early postoperatively after coronary artery bypass grafting (CABG) is a rare but dramatic complication, frequently making resuscitation necessary. Emergency reoperation with reanastomosing of the concerning grafts is the normal procedure to restrict the otherwise unavoidable myocardial damage. Mortality in these cases is up to 50%. Due to this unsatisfying situation, we perform since 1995 in such cases an adjuvant intraoperative intracoronary installed fibrinolysis with recombinant tissue type plasminogen activator (rt-PA; alteplase). Methods: Between 1/1994 and 8/1998, 4231 patients underwent CABG. In 18 of these patients, emergency reoperation within the first 12 h after CABG due to clinical signs of acute myocardial infarction was necessary. In nine of the patients (group II) additionally intraoperative rt-PA lysis of the involved vessel/s has been performed. When the peripheral anastomosis was reopened and the thrombotic material was removed, we inserted for this a left atrial-catheter (LA-catheter) of 1.2 mm in diameter, into the coronary artery. Then we administered within 3–5 min, up to 100 mg rt-PA (t1/2: 5–9 min.) locally into the vessel. All patients were treated postoperatively with acetylsalicyl acid (ASA) and heparine. Results: In group I (n=9; seven males, two females) without thrombolytic therapy, 78% of the patients (n=7) could not have been prevented from large myocardial infarction despite emergency reoperation. Three of these patients died during or early after reintervention. In group II with fibrinolytic therapy (n=9) three of the patients developed Q-wave myocardial infarction following reoperation. None of the patients died. Creatinkinase maximum were in group I significantly higher than in group II (group I: CK=1254 units/l, CK-MB=197 units/l; group II: CK=502 units/l, CK-MB=61 units/l; P<0.01). Postoperative bleeding was considerable elevated in both groups. In group I, 832 ml/24 h (375–1420 ml), in group II 1164 ml/24 h (520–1560 ml). Lysis-associated complications were not observed. Conclusions: Reoperation of patients with acute thrombotic bypass occlusion after CABG is characterized by a high mortality and morbidity. If additionally fibrinolysis is performed, a sufficient myocardial perfusion seems to be restored. A short half-life in combination with the presented non-systemic application technique of rt-PA seem to prevent unpredictable bleeding. Rt-PA lysis apparently contributes very effectively to the restoration of the macro- and microcirculation within the infarct-related area. Thrombolytic therapy during cardiac surgery with rt-PA is feasible, its application easy and harmful complications are not seen.

Key Words: Fibinolytics • Alteplase • Cardiac surgery • Intraoperative application • Bypass thrombosis




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Thielmann, P. Massoudy, B. R. Jaeger, M. Neuhauser, G. Marggraf, S. Sack, R. Erbel, and H. Jakob
Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 117 - 125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.